CACNA1A and urinary bladder neoplasm: In our previous study, BI-TK/GCV was constructed and proved effective in inhibiting the progressive growth of bladder tumor which was related to apoptosis in vivo [9], [10], indicating that BI-TK/GCV was a successful treatment system and might provide a novel strategy for treatment of advanced or metastatic bladder cancer in future.